Liz Hockley

Articles by Liz Hockley

Pharma

J&J settles Amgen clash over blockbuster psoriasis drug

Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.   25 May 2023

Pharma

Gilead defeats US govt in billion-dollar HIV drug patent suit

Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.   11 May 2023

Americas

BMS loses UK appeal over blood-thinning drug

Decision addresses issue of plausibility in invalidation verdict | Case marks first time that Court of Appeal judges held a patent with a single claim to a pharma compound invalid.   9 May 2023

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.   4 May 2023

article

Jury undecided whether Apple stole medtech trade secrets

Latest instalment in dispute over Apple Watch health functionality ends in mistrial | Verdict inconclusive as one out of seven jurors disagrees | Masimo had asked for more than $1.8 billion in damages.   2 May 2023

Americas

Judge: 3M should win COVID-19 price-gouging lawsuit

Judge enters default judgment as New Jersey-based firm failed to respond to suit | Defendant allegedly sought to sell 3M-branded masks at inflated prices during the pandemic.   2 May 2023

Pharma

European Commission proposes ‘single market’ for meds

Proposals include new regulatory protection periods for innovative drugs | Changes are aimed at improving patient access to therapeutics and boosting the EU pharma industry.   27 April 2023

Pharma

Cipla loses fightback over diarrhoea antibiotic

Judge rejects notion that tribunal acted unfairly in royalties dispute with Salix | Indian firm wanted payments on sales of antibiotic | Appeal brought under act with ‘high hurdle to surmount’.   25 April 2023

Americas

Lawsuit against Celgene, BMS and others moves forward

New Jersey judge denies motion to stay antitrust action regarding blockbuster cancer drug | Defendants had argued litigation would be unnecessary and costly.   25 April 2023

Pharma

Amgen secures five-year ban on psoriasis drug copycat

Court affirms decision that two Otezla patents are not invalid | Apremilast generics set for 2028 release.   20 April 2023

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.